Using Artificial Intelligence Graph Neural Networks To Repurpose Pre-existing Drugs and Analyze Drug Relationships: Year 2
ISEF · 2022 Computational Biology and Bioinformatics
Overview
As burgeoning crises have exposed failures of the drug discovery cycle - an inability to quickly and effectively develop new drugs - artificial intelligence-based drug repositioning models are emerging as an effective, less capital-intensive way to repurpose pre-existing drugs to treat new conditions. Two computational models were developed using data from DrugBank and deepSNAP libraries. The first model takes in user input regarding the effects of a condition and successfully provides suitable drug candidates, developing novel relationships by analyzing which drugs treat similar effects to the condition being researched. The second model consists of two artificial intelligence graph neural networks (GNNs). The GNNs consist of tens of thousands of nodes, representing drugs, and edges, representing relationships between drugs. This model can penalize and train itself to become more accurate. One GNN can successfully predict drug compatibility with accuracies up to 84% and the other can successfully predict FDA approval of drugs with accuracies up to 81%. Both models were additionally supplemented with an extra 10-15 thousand data points and other drug features such as drug-protein relationships and chemical structures to increase both accuracy and functionality. In addition to this, an application and dynamic user interface was created which packages both models into something that can be directly used by physicians and pharmaceutical companies. With the addition of the user interface and GNN to predict FDA approval, new opportunities for applications have been created including drug personalization, helping pharmaceutical companies and physicians with the user interface, and helping with pandemics and crisis response.
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2023
Using Artificial Intelligence Neural Networks to Repurpose Pre-Existing Drugs and Analyze Drug Relationships, Year 3
ISEF · 2021
A Novel Computational Approach to Drug Discovery Through Drug Repositioning
ISEF · 2026
AI-Driven Graph Neural Networks for Dual-Target AChE and BACE1 Drug Repurposing in Alzheimer’s Disease
ISEF · 2021
Novel Evolutionary Artificial Intelligence Methods for De Novo Drug Design
ISEF · 2022
Drug-Target Interactions Prediction Using Network Based Method and Machine Learning
ISEF · 2025
A Novel Computational Generative Model That Identifies Ligands: A Potential Way to Reduce Cost & Time in Identifying Promising Drug Candidates
ISEF · 2024
Leveraging Deep Learning Models to Identify Structurally Adequate Drug Candidates for Parkinson's Disease
ISEF · 2024
GraphChem: A Soft Graph Mixture of Experts Based Adversarial Variational Spectral Graph Autoencoder for De Novo Drug Design & Other Pharmacological Objectives
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair